« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 2
, Pages 475-482
, 1 October 2007
Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head and Neck Cancer
References
- . Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74–108
- Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003;25:953–959
- Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res. 2005;11:3987–4002
- Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J Neurooncol. 2003;62:87–99
- . Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view. J Neurooncol. 2003;62:101–109
- A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol. 2003;62:111–121
- Boron neutron capture therapy of brain tumors: Clinical trials at the Finnish facility using boronophenylalanine. J Neurooncol. 2003;62:123–134
- Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996
- Uptake of 4-borono-2-[(18)F]fluoro-L: -phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET. Eur J Nucl Med Mol Imaging. 2007;34:87–92
- ICRU. ICRU report 46, photon, electron, proton, and neutron interaction data for body tissues, International Committee on Radiation Units and Measurements: Bethesda, MD; 1992.
- . Review: The radiation biology of boron neutron capture therapy. Rad Res. 1999;151:1–18
- Boron neutron capture therapy (BNCT): Implications of neutron beam and boron compound characteristics. Med Phys. 1999;26:1237–1244
- Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT. Int J Radiat Oncol Biol Phys. 2000;48:1145–1154
- New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–216
- Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Int J Radiat Oncol Biol Phys. 2005;61:1096–1106
- Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:382–391
- Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy. Radiother Oncol. 2004;72:83–85
- First clinical case of boron neutron capture therapy for head and neck malignant. Head and Neck. 2006;28:850–855
- Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot. 2004;61:1069–1073
- Aihara T, Hiratsuka J, Nishiike S, et al. Using BPA alone for boron neutron capture therapy of recurrent head and neck malignancies. In: Nagakawa Y, Kobayashi T, Fukuda H, editors. Proceedings 12th International Congress on Neutron Capture Therapy, Takamatsu, Japan, October 9–12, 2006. p. 5–6.
- Ariyoshi Y, Shimahara M, Kimura Y, et al. Boron neutron capture therapy for advanced and/or recurrent cancers in the oral cavity. In: Nagakawa Y, Kobayashi T, Fukuda H, editors. Proceedings 12th International Congress on Neutron Capture Therapy, Takamatsu, Japan. October 9–12, 2006. p. 10–13.
- Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. Int J Radiat Oncol Biol Phys. 1998;40:829–834
Presented at the 12th International Congress on Neutron Capture Therapy, Takamatsu, Kagawa, Japan, October 9–13, 2006.
Supported by grants from the Academy of Finland and Helsinki University Central Hospital research funds. L.K., T.S., H.K., J.C., M. Kortesniemi, J.U.-S., S.S., and M. Kouri have received financial compensation from Boneca Corporation Ltd for the work done to treat BNCT patients. H.J. has received financial compensation from Boneca Corporation Ltd for consultations. H.K. is an employee of Boneca Corporation Ltd.
PII: S0360-3016(07)00555-X
doi: 10.1016/j.ijrobp.2007.03.039
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 2
, Pages 475-482
, 1 October 2007
